Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce Chackerian

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
NPJ Vaccines|September 28, 2023
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanylIsabella G Romano, Brandi Johnson-Weaver, Susan B Core, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human PrimatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
NPJ Vaccines|March 28, 2025
Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanylIsabella G Romano, Brandi Johnson-Weaver, Susan B Core, et al.
Vaccines|December 18, 2020
Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion PeptideAlemu Tekewe Mogus, Lihong Liu, Manxue Jia, et al.
Vaccines|January 22, 2022
Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against <i>Chlamydia trachomatis</i> Type 3 Secretion System Tip Protein, CT584Everett Webster, Kyra W Seiger, Susan B Core, et al.
Advanced Healthcare Materials|November 28, 2012
Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayersKatharine Epler, David Padilla, Genevieve Phillips, et al.
EMBO Molecular Medicine|July 29, 2017
Going viral? Linking the etiology of human prostate cancer to the <i>PCA3</i> long noncoding RNA and oncogenic virusesAndre A Teixeira, Serena Marchiò, Emmanuel Dias-Neto, et al.
Immunity|September 30, 2019
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza VirusMaya Sangesland, Larance Ronsard, Samuel W Kazer, et al.
ACS Nano|May 28, 2011
Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particlesCarlee E Ashley, Eric C Carnes, Genevieve K Phillips, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
NPJ Vaccines|September 28, 2023
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanylIsabella G Romano, Brandi Johnson-Weaver, Susan B Core, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human PrimatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
NPJ Vaccines|March 28, 2025
Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanylIsabella G Romano, Brandi Johnson-Weaver, Susan B Core, et al.
Vaccines|December 18, 2020
Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion PeptideAlemu Tekewe Mogus, Lihong Liu, Manxue Jia, et al.
Vaccines|January 22, 2022
Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against <i>Chlamydia trachomatis</i> Type 3 Secretion System Tip Protein, CT584Everett Webster, Kyra W Seiger, Susan B Core, et al.
Advanced Healthcare Materials|November 28, 2012
Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayersKatharine Epler, David Padilla, Genevieve Phillips, et al.
EMBO Molecular Medicine|July 29, 2017
Going viral? Linking the etiology of human prostate cancer to the <i>PCA3</i> long noncoding RNA and oncogenic virusesAndre A Teixeira, Serena Marchiò, Emmanuel Dias-Neto, et al.
Immunity|September 30, 2019
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza VirusMaya Sangesland, Larance Ronsard, Samuel W Kazer, et al.
ACS Nano|May 28, 2011
Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particlesCarlee E Ashley, Eric C Carnes, Genevieve K Phillips, et al.
Pageof 10